Sophie Vouyovitch-Pittion

Nancy, 54000, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Cerebrospinal fluid levels of chitinase 3-like 1 and interleukin-6 can predict response to platform therapies in relapsing multiple sclerosis.

Cerebrospinal fluid levels of chitinase 3-like 1 and interleukin-6 can predict response to platform therapies in relapsing multiple sclerosis.

Journal: Journal of neurology

Published: May 22, 2025

Prevalence of SOD1 and C9orf72 Variants Among French ALS Population: The GENIALS Study.

Prevalence of SOD1 and C9orf72 Variants Among French ALS Population: The GENIALS Study.

Journal: European journal of neurology

Published: May 01, 2025

Pregnancy and birth outcomes in women with multiple sclerosis: Comparison of the RESPONSE study to the general French population.

Pregnancy and birth outcomes in women with multiple sclerosis: Comparison of the RESPONSE study to the general French population.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: March 18, 2025

Mild cognitive dysfunction in hereditary spastic paraplegia 4 disease related to fluorodesoxyglucose cerebral positron emission tomography.

Mild cognitive dysfunction in hereditary spastic paraplegia 4 disease related to fluorodesoxyglucose cerebral positron emission tomography.

Journal: Brain communications

Published: January 09, 2025

Caffeine consumption outcomes on amyotrophic lateral sclerosis disease progression and cognition.

Caffeine consumption outcomes on amyotrophic lateral sclerosis disease progression and cognition.

Journal: Neurobiology of disease

Published: April 22, 2024

Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study.

Risk of secondary progression in patients with highly active multiple sclerosis treated with natalizumab: a real-life study.

Journal: Journal of neurology

Published: September 04, 2023

Real-life evaluation of the 2017 McDonald criteria for relapsing-remitting multiple sclerosis after a clinically isolated syndrome confirms a gain in time-to-diagnosis.

Real-life evaluation of the 2017 McDonald criteria for relapsing-remitting multiple sclerosis after a clinically isolated syndrome confirms a gain in time-to-diagnosis.

Journal: Journal of neurology

Published: May 25, 2023

Secondary progressive multiple sclerosis: A national consensus paper on diagnostic criteria.

Secondary progressive multiple sclerosis: A national consensus paper on diagnostic criteria.

Journal: Revue neurologique

Published: March 29, 2022

Clinical and radiological activity of secondary progressive multiple sclerosis in a population-based cohort.

Clinical and radiological activity of secondary progressive multiple sclerosis in a population-based cohort.

Journal: European journal of neurology

Published: March 04, 2021

Long-term analysis of patients with benign multiple sclerosis: new insights about the disability course.

Long-term analysis of patients with benign multiple sclerosis: new insights about the disability course.

Journal: Journal of neurology

Published: October 20, 2020

Effect of familial clustering in the genetic screening of 235 French ALS families.

Effect of familial clustering in the genetic screening of 235 French ALS families.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: September 06, 2020

Discontinuation of disease-modifying treatments for multiple sclerosis in patients aged over 50 with disease Inactivity.

Discontinuation of disease-modifying treatments for multiple sclerosis in patients aged over 50 with disease Inactivity.

Journal: Journal of neurology

Published: April 01, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026